In pancreatic cancer, the expression of HSP27 and the phosphorylated HSP27 state are considered to play a critical role in gemcitabine resistance [10,28,29,30,31,32,33,34]. This evidence concerns the gene HSPB1 and familial pancreatic carcinoma.